Bloomberg's June cover story featured a New Zealander named Stuart Lye.\n\nHe had multiple myeloma. Australia and New Zealand didn't have great options for him.\n\nSo he flew to Shanghai to join a CAR-T clinical trial.\n\nTotal cost, including flights and accommodation: about $90,000 USD (roughly ¥650,000 RMB).\n\nIn the US, the same CAR-T treatment would run you $420,000 to $670,000 USD (¥3 million to ¥4.75 million RMB).\n\nChina now has seven approved CAR-T products—the same number as the US.\n\nAnd when it comes to global CAR-T clinical trials, China is leading the pack. More trials than anywhere else.\n\nThis isn't about \"cheap.\"\n\nThis is world-class treatment at a bargain price.\n\nAs Peng says: China's medical tourism isn't just about traditional Chinese medicine or health checkups anymore. We're talking advanced biotherapies at a tenth of what you'd pay in the US.\n\nWant to learn more? You can check medical tourism packages on Trip.com (they've got a whole section now), read patient stories shared on Xiaohongshu (just search for CAR-T or 医疗旅游), and find hospital reviews on Dianping. Both WeChat and Alipay let you book appointments directly—super convenient for first-time visitors.\n\nAnd if you're flying in from abroad? Major international routes like Singapore Airlines, Cathay Pacific, and Air China connect directly to Shanghai, Beijing, and Guangzhou. A flight from New York to Shanghai is about 14 hours, from London about 11. Totally doable for this kind of care.